πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 812 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10329552

Vaccine for livestock production systems

The Regents of the University of California Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10328139

Live-attenuated vaccine against plague

The Board of Regents of the University of Texas System Β· Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10322171

Vaccine with reduced enhancement of viral infection

The Board of Regents of the University of Texas System Β· Granted Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10314904

Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10307476

Genetically stable live attenuated respiratory syncytial virus vaccine and its production

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10300134

Vaccine formulations and methods of preparation and use thereof

Tejas Discovery and Research, LLC Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10300123

Synthetic peptide-based marker vaccine and diagnostic system for effective control of porc

United Biomedical, Inc. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10301393

Methods of treating multiple sclerosis using anti-CD20 antibodies

VACCINEX, INC. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10300130

Cytomegalovirus vaccines and methods of production

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10293037

DNA vaccine for use in pancreatic cancer patients

Vaximm AG Β· Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10286050

Multi-epitope TARP peptide vaccine and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10286054

Attenuated EHEC and clostridial toxins TcdA and TcdB based vaccine for Clostridium diffici

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10286064

Cationic lipid vaccine compositions and methods of use

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10279023

Mucin-associated surface protein as a vaccine against chagas disease

The Board of Regents of the University of Texas System Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10273292

Non-HIV vaccine antigen from the vaginal microbiota capable of inducing a mucosal neutrali

B Cell Design SAS Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10272146

Purified plasmodium and vaccine compositions

Sanaria Inc. Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10265394

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10258682

Attenuated chlamydia vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10238734

Compositions and methods for self-adjuvanting vaccines against microbes and tumors

The Regents of the University of California Β· Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10232030

Vaccines for human papilloma virus and methods for using the same

Inovio Pharmaceuticals, Inc. Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10233429

Hand, foot, and mouth vaccines and methods of manufacture and use thereof

Takeda Vaccines, Inc. Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10232035

Conditionally replication deficient herpes virus and use thereof in vaccines

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226523

Clostridium difficile vaccine and methods of use

The Board of Regents of the University of Oklahoma Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10226526

Vaccines for human papilloma virus and methods for using the same

Inovio Pharmaceuticals, Inc. Β· Granted Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted